Welcome to Markets Desk, here's what's moving the needle right now.
Warren Buffett's latest warning is drawing attention across trading desks this morning. The Shiller CAPE ratio, a long-run valuation measure, suggests U.S. equities are sitting at historically elevated levels, and Buffett's eleven-word caution is prompting serious investors to revisit their risk exposure heading into the back half of the year.
Shifting to the ETF space, the debate between VTI and IWM is heating up as small-caps show renewed momentum. The iShares Russell two thousand has outperformed large-caps in recent sessions, but the longer track record still favors broad market exposure through VTI. Investors chasing short-term rotation need to weigh that historical context carefully before repositioning.
And in biotech, Viking Therapeutics is generating real buzz among growth investors. The company could have a commercial product on the market within two years, and speculation around what a thousand-dollar stake today might be worth by two thousand thirty is driving meaningful retail interest. Pipeline execution remains the critical variable between promise and payoff.
That's the tape. Markets Desk, signing off the floor.
